Raycaster vs Clarivate Tradeoffs
Raycaster
This is a classic incumbent versus workflow startup split, where Clarivate wins on depth and geographic breadth, while newer entrants win on speed and fit for day to day drafting. Cortellis Regulatory Intelligence is built on more than 30 years of regulatory expertise and covers 80 plus markets, which makes it strong for cross country reference work. But Raycaster is aiming at the actual document handoffs where teams lose weeks, like turning sponsor packets into sourced responses, or drafting Module 3 sections inside existing biotech workflows.
-
Clarivate sells a content rich reference layer. Its Regulatory Assistant sits inside Cortellis Regulatory Intelligence, gives cited answers, and is layered onto a long standing paid database. That usually means customers are buying trusted coverage first, then AI access on top, which supports premium pricing.
-
Newer tools compete by reducing the work between documents, not by owning the biggest archive. Raycaster plugs into systems like Veeva, IQVIA, SharePoint, and LIMS, then flags missing pieces, drafts the next artifact, and routes review to the right person. That is a faster shipping surface because the workflow is narrower and closer to the user action.
-
The practical buyer tradeoff is clear. A large pharma team doing multi country regulatory research may pay up for Clarivate because broad historical coverage lowers the risk of missing a requirement. A biotech, CRO, or CDMO under timeline pressure may choose an AI native tool that gets a messy packet into a reviewable draft in hours instead of days.
The market is moving toward a stack where proprietary reference databases become inputs, and workflow native agents become the interface. Clarivate is already pushing its data into external AI environments through Claude integration, while startups are pushing deeper into regulated document creation. The winners will combine trusted source depth with faster, embedded execution inside the systems teams already use.